News > Coronavirus: India’s drug regulator approves study on mixing vaccines

Coronavirus: India’s drug regulator approves study on mixing vaccines

The Drugs Controller General of India has approved a study on mixing Covid-19 vaccines Covishield and Covaxin, the Centre said at a press briefing on Tuesday. In July, the Central Drugs Standard Control Organisation’s Subject Expert Committee had recommended allowing the institute to conduct the study, PTI had reported.

“To my knowledge, there was a study on mixing vaccines to be done by CMC [Christian Medical College] Vellore [in Tamil Nadu],” NITI Aayog Member (Health) Dr VK Paul told reporters. “The permission for the research study has been granted.”